What the six lenses say about PPLPHARMA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How PPLPHARMA’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +2.0pp | +3.1pp | +1.6pp | +18.2pp | +8.8pp | -8.8pp |
Nifty 500 Broad-market baseline | +1.6pp | +3.0pp | +1.0pp | +14.5pp | +3.7pp | -12.6pp |
Sector Own-sector index | — | — | -1.4pp | +2.1pp | -10.7pp | -30.5pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
PPLPHARMA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
PPLPHARMA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 1,951 | 2,242 | 2,204 | 2,754 | 1,934 | 2,044 | 2,140 | 2,752 |
| ↳ change QoQ | — | +14.9% | -1.7% | +24.9% | -29.8% | +5.7% | +4.7% | +28.6% |
| EBITDA (₹cr) | 224 | 403 | 350 | 561 | 107 | 159 | 196 | 461 |
| EBITDA margin | 11.5% | 18.0% | 15.9% | 20.4% | 5.5% | 7.8% | 9.2% | 16.7% |
| PAT (₹cr) | -89 | 23 | 4 | 154 | -82 | -99 | -136 | -9 |
| ↳ change QoQ | — | +125.5% | -83.7% | +4071.2% | -153.2% | -21.4% | -37.3% | +93.5% |
| Net margin | -4.5% | 1.0% | 0.2% | 5.6% | -4.2% | -4.9% | -6.4% | -0.3% |
| EPS (₹) | -0.67 | 0.17 | 0.03 | 1.16 | -0.61 | -0.75 | -1.02 | -0.07 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding PPLPHARMA (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| HDFC Flexi Cap Gr | 1.53% | 1,01,822 | |
| Bandhan Small Cap Reg Gr | 0.63% | 27,219 | |
| Canara Robeco Small Cap Reg Gr | 0.74% | 13,967 | |
| Nippon India Pharma Bns | 1.02% | 9,044 | |
| Nippon India Pharma Gr | 1.02% | 9,044 | |
| Canara Robeco ELSS Tax Saver Reg Gr | 0.56% | 8,637 | |
| Bajaj Finserv Flexi Cap Reg Gr | 1.19% | 7,195 | |
| Aditya BSL Small Cap Gr | 0.68% | 5,453 | |
| Franklin India Multi Cap Reg Gr | 0.58% | 4,892 | |
| Bajaj Finserv Large & Mid Cap Reg Gr | 0.90% | 2,326 |
ETFs holding PPLPHARMA (10)